##gff-version 3
##sequence-region Q765P7 1 747
Q765P7	UniProtKB	Chain	1	747	.	.	.	ID=PRO_0000319610;Note=MTSS1-like protein	
Q765P7	UniProtKB	Domain	1	252	.	.	.	Note=IMD;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00668	
Q765P7	UniProtKB	Domain	719	736	.	.	.	Note=WH2	
Q765P7	UniProtKB	Coiled coil	135	159	.	.	.	Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q765P7	UniProtKB	Compositional bias	252	383	.	.	.	Note=Ser-rich	
Q765P7	UniProtKB	Modified residue	260	260	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q6P9S0	
Q765P7	UniProtKB	Modified residue	264	264	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q6P9S0	
Q765P7	UniProtKB	Modified residue	441	441	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:20068231;Dbxref=PMID:18669648,PMID:20068231	
Q765P7	UniProtKB	Modified residue	579	579	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q765P7	UniProtKB	Modified residue	601	601	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:23186163,ECO:0000244|PubMed:24275569;Dbxref=PMID:18220336,PMID:23186163,PMID:24275569	
Q765P7	UniProtKB	Modified residue	612	612	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:23186163;Dbxref=PMID:18669648,PMID:23186163	
Q765P7	UniProtKB	Modified residue	624	624	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q765P7	UniProtKB	Modified residue	634	634	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18669648;Dbxref=PMID:18669648	
Q765P7	UniProtKB	Modified residue	639	639	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:18220336,ECO:0000244|PubMed:18669648,ECO:0000244|PubMed:24275569;Dbxref=PMID:18220336,PMID:18669648,PMID:24275569	
Q765P7	UniProtKB	Modified residue	643	643	.	.	.	Note=Phosphothreonine;Ontology_term=ECO:0000244;evidence=ECO:0000244|PubMed:18220336;Dbxref=PMID:18220336	
Q765P7	UniProtKB	Alternative sequence	153	155	.	.	.	ID=VSP_031513;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q765P7	UniProtKB	Alternative sequence	264	294	.	.	.	ID=VSP_031514;Note=In isoform 2. SPSSSSSRKSSMCSAPSSSSSAKGGGAPWPG->VPSEPFVSFLSVRFWKNSPLLPAPSTPSSPI;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q765P7	UniProtKB	Alternative sequence	295	747	.	.	.	ID=VSP_031515;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:15489334;Dbxref=PMID:15489334	
Q765P7	UniProtKB	Mutagenesis	115	115	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	116	116	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	123	123	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	127	127	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	130	130	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	137	137	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	138	138	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-139%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	139	139	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-145%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	145	145	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-148%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	148	148	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-149%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	149	149	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-152 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	152	152	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149 and D-157. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
Q765P7	UniProtKB	Mutagenesis	157	157	.	.	.	Note=Marked reduction in RAC1-binding%2C loss of increase in RAC1 activity and of dorsal ruffles formation in response to PDGF treatment%3B when associated with D-115%2C D-116%2C D-123%2C D-127%2C D-130%2C D-137%2C D-138%2C D-139%2C D-145%2C D-148%2C D-149 and D-152. K->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20875796;Dbxref=PMID:20875796	
